Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOCUREX INC (BOCX) -- Ignore unavailable to you. Want to Upgrade?

To: scion who wrote (12)	3/10/2003 11:37:50 PM
From: scion	Read Replies (1) \| Respond to of 21

United States Patent 6,514,685 Moro February 4, 2003 -------------------------------------------------------------------------------- Detection of cancer using antibodies to the alphafeto protein receptor Abstract A method for detecting cancer in a patient. The method comprises the steps of introducing labeled antibodies or labeled AFP to a biological sample of the patient so the labeled antibodies or labeled AFP will react with the AFP receptor binding sites in the biological sample. Next there is the step of identifying AFP receptor binding sites in the biological material which are reacted with the labeled antibodies or labeled AFP to determine the presence of cancer. -------------------------------------------------------------------------------- Inventors: Moro; Ricardo J. (1007-1625 W. 13th Avenue, Vancouver, CA) Appl. No.: 920654 Filed: August 15, 1997 Current U.S. Class: 435/4; 435/7.1; 435/7.21; 435/40.5; 435/7.23; 435/7.7; 435/7.9; 435/40.51; 435/40.52 Intern'l Class: C12Q 001/00; G01N 033/53; G01N 033/567; G01N 001/30 Field of Search: 435/7.1,7.8,40.5,4,7.21,7.23,7.7,7.9,40.51,40.52 530/391.1 424/1.11,9.34 patft.uspto.gov